Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KCNA5 | P22460 | 9/20 | 0.57 |
| ▸ | KCNH2 | Q12809 | 8/20 | 0.57 |
| ▸ | DPP4 | P27487 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | BRD4 | O60885 | 2/20 | 0.40 |
| ▸ | LCK | P06239 | 1/20 | 0.39 |
| ▸ | AS3MT | Q9HBK9 | 1/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3622700 | 0.91 | KCNA5 (0.61) | KCNA5KCNH2DPP4ALDH1A1KDM4E | |
| SCHEMBL3619772 | 0.88 | KCNA5 (0.58) | KCNA5KCNH2DPP4ALDH1A1KDM4E | |
| SCHEMBL3624281 | 0.88 | KCNA5 (0.58) | KCNA5KCNH2DPP4ALDH1A1KDM4E | |
| SCHEMBL3616349 | 0.87 | KCNA5 (0.64) | KCNA5KCNH2DPP4ALDH1A1KDM4E | |
| SCHEMBL3623049 | 0.87 | KCNA5 (0.74) | KCNA5KCNH2DPP4ALDH1A1KDM4E | |
| SCHEMBL3619430 | 0.87 | KCNA5 (0.57) | KCNA5KCNH2DPP4ALDH1A1KDM4E | |
| SCHEMBL3619470 | 0.85 | KCNA5 (0.54) | KCNA5KCNH2DPP4ALDH1A1KDM4E | |
| SCHEMBL1381734 | 0.84 | KCNA5 (0.68) | KCNA5KCNH2ALDH1A1KDM4E | |
| SCHEMBL3625281 | 0.83 | KCNA5 (0.56) | KCNA5KCNH2SMN1; SMN2MAPK8 | |
| SCHEMBL3624592 | 0.82 | KCNA5 (0.58) | KCNA5KCNH2DPP4ALDH1A1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7763614-B2 | Isoquinoline potassium channel inhibitors | MERCK SHARP & DOHME CORP. (US) | 2010-07-27 | — | — | US | claimed |
| US-20070054892-A1 | Isoquinoline potassium channel inhibitors | MERCK SHARP & DOHME CORP. | 2007-03-08 | — | — | US | claimed |
| US-7763614-B2 | Isoquinoline potassium channel inhibitors | MERCK SHARP & DOHME CORP. (US) | 2010-07-27 | — | — | US | disclosed |
| US-20070054892-A1 | Isoquinoline potassium channel inhibitors | MERCK SHARP & DOHME CORP. | 2007-03-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070054892-A1 | Isoquinoline potassium channel inhibitors | KCNQ1, KCNQ2, KCNQ5 | KCNA5 14/4885KCNH2 5/4885DPP4 2227/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.